Success Metrics

Clinical Success Rate
69.2%

Based on 9 completed trials

Completion Rate
69%(9/13)
Active Trials
2(13%)
Results Posted
56%(5 trials)
Terminated
4(27%)

Phase Distribution

Ph not_applicable
2
13%
Ph phase_1
5
33%
Ph phase_4
3
20%
Ph phase_3
4
27%
Ph phase_2
1
7%

Phase Distribution

5

Early Stage

1

Mid Stage

7

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
5(33.3%)
Phase 2Efficacy & side effects
1(6.7%)
Phase 3Large-scale testing
4(26.7%)
Phase 4Post-market surveillance
3(20.0%)
N/ANon-phased studies
2(13.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

69.2%

9 of 13 finished

Non-Completion Rate

30.8%

4 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(2)
Completed(9)
Terminated(4)

Detailed Status

Completed9
Terminated4
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
69.2%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (33.3%)
Phase 21 (6.7%)
Phase 34 (26.7%)
Phase 43 (20.0%)
N/A2 (13.3%)

Trials by Status

recruiting213%
terminated427%
completed960%

Recent Activity

2 active trials
Showing 5 of 15
recruitingphase_4

Ventilation and Perfusion in Asthmatics

NCT07426458
recruitingphase_3

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

NCT06052267
terminatedphase_1

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

NCT05035862
completedphase_3

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

NCT00665600
completedphase_3

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

NCT02969408
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07426458Phase 4

Ventilation and Perfusion in Asthmatics

Recruiting
NCT06052267Phase 3

A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations

Recruiting
NCT05035862Phase 1

Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma

Terminated
NCT00665600Phase 3

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Completed
NCT02969408Phase 3

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

Completed
NCT03586544Phase 4

Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity

Terminated
NCT03098680Phase 1

A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems

Terminated
NCT02766673Not Applicable

Aerosolized Albuterol Use in Severe BPD

Completed
NCT00394329Phase 3

(CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)

Completed
NCT03091504Not Applicable

Evaluation on the Efficacy of Bronchodilator Nebulization Via High Flow Nasal Cannula

Completed
NCT03480997Phase 1

Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD

Completed
NCT02566252Phase 1

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

Completed
NCT00434993Phase 2

Drug Study of Albuterol to Treat Acute Lung Injury

Terminated
NCT00667797Phase 4

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

Completed
NCT00565591Phase 1

Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15